Emmessar Biotech & Nutrition Limited (BOM:524768)

BOM:524768 Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	75.43	0.34	0.11	0.13	0.12	1.82
Short-Term Investments	0.11	72.93	68.71	61.79	51.89	44.1
Cash & Short-Term Investments	75.53	73.27	68.81	61.92	52	45.92
Cash Growth	4.84%	6.47%	11.14%	19.06%	13.25%	85.27%
Accounts Receivable	0.17	0.17	0.18	0.22	0.11	0.13
Other Receivables	-	2.53	2.6	-	0.9	1.14
Receivables	1.48	2.94	3.08	0.36	1.1	1.33
Inventory	0.95	0.97	1.24	0.89	1.36	0.68
Prepaid Expenses	-	0.91	0.93	0.96	0.67	0.55
Other Current Assets	4.19	2.5	1.98	4.19	4.21	0.14
Total Current Assets	82.16	80.58	76.04	68.32	59.34	48.61
Property, Plant & Equipment	10.98	11.38	12.21	13.09	13.97	14.55
Long-Term Deferred Tax Assets	-	-	-	-	-	2.78
Other Long-Term Assets	5.79	5.84	5.93	6.02	6.12	6.19
Total Assets	98.93	97.8	94.18	87.43	79.43	72.14

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	0.08	0.06	0.03	0.09	-	0.22
Accrued Expenses	-	4.36	3.78	3.85	3.38	2.99
Short-Term Debt	-	-	-	1.09	0.82	-
Current Income Taxes Payable	-	1.77	2.73	-	-	-
Other Current Liabilities	4.82	0.17	0.17	-	-0	0.09
Total Current Liabilities	4.9	6.36	6.71	5.04	4.2	3.3
Pension & Post-Retirement Benefits	-	1.69	1.31	1.09	1.12	1
Long-Term Deferred Tax Liabilities	2.58	2.78	3.15	1.13	1.32	-
Other Long-Term Liabilities	7.58	5.84	5.94	6.14	6.14	6.14
Total Liabilities	15.06	16.66	17.1	13.41	12.78	10.45

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	49.96	49.96	49.96	49.96	49.96	49.96
Retained Earnings	-	32.32	27.96	24.8	17.31	12.27
Comprehensive Income & Other	33.91	-1.14	-0.84	-0.74	-0.62	-0.54
Shareholders' Equity	83.87	81.15	77.08	74.02	66.65	61.69
Total Liabilities & Equity	98.93	97.8	94.18	87.43	79.43	72.14

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	-	-	-	1.09	0.82	-
Net Cash (Debt)	75.53	73.27	68.81	60.82	51.18	45.92
Net Cash Growth	4.84%	6.47%	13.14%	18.83%	11.46%	85.27%
Net Cash Per Share	15.07	14.67	13.77	12.17	10.24	9.19
Filing Date Shares Outstanding	5.01	5	5	5	5	5
Total Common Shares Outstanding	5.01	5	5	5	5	5
Working Capital	77.26	74.23	69.34	63.28	55.14	45.31
Book Value Per Share	16.74	16.24	15.43	14.82	13.34	12.35
Tangible Book Value	83.87	81.15	77.08	74.02	66.65	61.69
Tangible Book Value Per Share	16.74	16.24	15.43	14.82	13.34	12.35
Buildings	-	15.4	15.4	15.4	15.4	15.4
Machinery	-	5.13	5.04	5.04	5.04	4.78

Data Source: S&P Global Market Intelligence Last updated: Oct 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error